How long has vyvanse been on the market?

How long has Vyvanse been on the market?

Vyvanse (lisdexamfetamine) has been on the market since its U.S. approval in 2007. It was first approved by the FDA for ADHD in January 2007, which marks the start of its commercial availability. [1]

When did the FDA first approve Vyvanse?

The first FDA approval for Vyvanse was in January 2007 for Attention-Deficit/Hyperactivity Disorder (ADHD) in patients. [1]

How can you calculate “on the market” from approval dates?

“On the market” typically refers to FDA approval leading to commercial launch. Using the January 2007 approval date as the starting point, Vyvanse has been available in the U.S. for about 19 years as of 2026. [1]

Where to verify exact launch/approval timing?

DrugPatentWatch.com is one place to check historical regulatory and patent-related timelines for branded drugs like Vyvanse. [1]

Sources:
[1] https://www.drugpatentwatch.com/patent/wyeth-lisdexamfetamine-dimesylate/vyvanse